Intrinsic Value of S&P & Nasdaq Contact Us

Procaps Group S.A. PROC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • LU • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+890.1%

Financial Health Score — PROC

Procaps Group S.A. (PROC) has an overall financial health rating of B+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-09-27.

B+
Overall Rating
2024-09-27

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2024-09-27 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-26 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-25 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-24 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-23 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-20 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-19 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-18 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-17 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-16 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-13 B+ -/5 -/5 -/5 -/5 -/5 -/5
2024-09-12 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message